Dr. Reddy's Laboratories
RDY
#1729
Rank
ยฃ8.70 B
Marketcap
ยฃ10.41
Share price
0.22%
Change (1 day)
-7.73%
Change (1 year)

Revenue for Dr. Reddy's Laboratories (RDY)

Revenue in 2025 (TTM): ยฃ3.00 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current revenue (TTM ) is ยฃ2.97 Billion. In 2024 the company made a revenue of ยฃ2.94 Billion an increase over the revenue in the year 2023 that were of ยฃ2.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dr. Reddy's Laboratories from 2002 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ3.00 B2.07%
2024 ยฃ2.94 B14.49%
2023 ยฃ2.57 B4.93%
2022 ยฃ2.45 B18.41%
2021 ยฃ2.07 B12.58%
2020 ยฃ1.84 B-0.54%
2019 ยฃ1.85 B8.75%
2018 ยฃ1.70 B4.58%
2017 ยฃ1.62 B-5.61%
2016 ยฃ1.72 B5.7%
2015 ยฃ1.63 B7.94%
2014 ยฃ1.51 B13.25%
2013 ยฃ1.33 B12.65%
2012 ยฃ1.18 B-2.19%
2011 ยฃ1.21 B18.79%
2010 ยฃ1.01 B7.83%
2009 ยฃ0.94 B-1.69%
2008 ยฃ0.96 B49.51%
2007 ยฃ0.64 B1.2%
2006 ยฃ0.63 B111.82%
2005 ยฃ0.30 B30.86%
2004 ยฃ0.22 B-3.12%
2003 ยฃ0.23 B3.66%
2002 ยฃ0.22 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
ยฃ47.17 B 1,486.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.60 B 323.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ31.82 B 970.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
ยฃ42.35 B 1,324.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ35.71 B 1,100.85%๐Ÿ‡ซ๐Ÿ‡ท France